Literature DB >> 1116872

Immune response to hepatitis B surface antigen.

A B Ibrahim, G N Vyas, H A Perkins.   

Abstract

A total of 69 persons were investigated for assessment of cell-mediated and humoral immunity to hepatitis B surface antigen (HBsAg). Three groups, each consisting of 20 normal persons, 20HBsAg carriers, and 20 convalescent hepatitis B patients, were studied for HBsAg, anti-HBs, and leukocyte migration inhibition with purified HBsAg. Sequential sampling if an additional group of nine acute hepatitis B patients defined the cellular and humoral immune response to HBsAg. The antigen was eliminated rapidly by mounting of cell-mediated immune response detectable for a limited period, followed by antibody response in relatively few patients moore than 3 months after clearance of circulating HBsAg.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1116872      PMCID： PMC415036          DOI： 10.1128/iai.11.1.137-141.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  A "NEW" ANTIGEN IN LEUKEMIA SERA.

Authors:  B S BLUMBERG; H J ALTER; S VISNICH
Journal:  JAMA       Date:  1965-02-15       Impact factor: 56.272

2.  Immunological studies of Australia antigen carriers with and without liver diseases.

Authors:  J O Nielsen; V Reinicke; O Dietrichson; V Andersen; M Thomsen; E Andersen
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

3.  Inhibitory effect of Australia-positive sera on in-vitro-stimulated T lymphocytes.

Authors:  J Clot; O Mathieu; S Elharrar; M Robinet-Levy; J M Lemaire
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

4.  Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen.

Authors:  V Giustino; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

5.  Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees.

Authors:  A B Ibrahim; G N Vyas; A M Prince
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

6.  Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.

Authors:  S Krugman; J P Giles
Journal:  N Engl J Med       Date:  1973-04-12       Impact factor: 91.245

7.  Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.

Authors:  A A Laiwah; A K Chaudhuri; J R Anderson
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

8.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

Review 9.  Epidemiology of serum hepatitis.

Authors:  Y E Cossart
Journal:  Br Med Bull       Date:  1972-05       Impact factor: 4.291

Review 10.  Hepatitis-associated antigen.

Authors:  N R Shulman
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965
View more
  20 in total

1.  Prevalence of hepatitis B antibodies in hospital personnel.

Authors:  W D Leers; G M Kouroupis
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262

2.  Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection.

Authors:  A Nicole; O Spertini; D Lavanchy; P C Frei
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

3.  Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus.

Authors:  S Vento; S H Chen; G Giuliani-Piccari; C J O'Brien; P R Dal Monte; A L Eddleston; C R Howard; R Williams
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

4.  Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.

Authors:  M L Tiku; K R Beutner; P L Ogra
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

5.  Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.

Authors:  K R Beutner; M L Tiku; P L Ogra
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  Anti-idiotypic humoral and cellular responses to antibody to hepatitis B surface antigen in hepatitis B viral infections.

Authors:  S Rath; V Bal; B J Mohite; V Haridas; S R Naik; S A Kamat; A J Zuckerman; R S Kamat
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

7.  Influence of (+)-cyanidanol-3 on the leukocyte migration inhibition test carried out in the presence of purified protein derivative and hepatitis B surface antigen.

Authors:  J J Vallotton; P C Frei
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.

Authors:  B Hafkin; R B Pollard; M L Tiku; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  Cell-mediated immunity to hepatitis B surface antigen in man.

Authors:  R G Hanson; J H Hoofnagle; G Y Minuk; R H Purcell; J L Gerin
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

10.  Cellular immunity to the hepatitis B virion in acute hepatitis type B.

Authors:  G Fattovich; A Alberti; C Crivellaro; P Pontisso; F Noventa; G Realdi
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.